Zinc in PDB 3s45: Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
Enzymatic activity of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
All present enzymatic activity of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir:
3.4.23.47;
Protein crystallography data
The structure of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir, PDB code: 3s45
was solved by
Y.-F.Tie,
Y.-F.Wang,
I.T.Weber,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
10.00 /
1.51
|
Space group
|
C 1 2 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
105.998,
30.986,
56.161,
90.00,
91.66,
90.00
|
R / Rfree (%)
|
18.3 /
24.6
|
Other elements in 3s45:
The structure of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
(pdb code 3s45). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 7 binding sites of Zinc where determined in the
Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir, PDB code: 3s45:
Jump to Zinc binding site number:
1;
2;
3;
4;
5;
6;
7;
Zinc binding site 1 out
of 7 in 3s45
Go back to
Zinc Binding Sites List in 3s45
Zinc binding site 1 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn533
b:43.0
occ:0.50
|
CL
|
A:CL513
|
0.9
|
37.3
|
0.5
|
O
|
A:LEU99
|
2.6
|
38.7
|
1.0
|
N3
|
A:IMD524
|
2.6
|
30.1
|
0.5
|
O
|
A:HOH1080
|
2.7
|
25.5
|
1.0
|
C4
|
A:IMD524
|
3.0
|
30.2
|
0.5
|
C
|
A:LEU99
|
3.5
|
34.1
|
1.0
|
OXT
|
A:LEU99
|
3.6
|
41.5
|
1.0
|
C2
|
A:IMD524
|
3.9
|
31.0
|
0.5
|
C5
|
A:IMD524
|
4.3
|
30.1
|
0.5
|
N1
|
A:IMD524
|
4.7
|
30.8
|
0.5
|
CA
|
A:LEU99
|
4.8
|
28.3
|
1.0
|
|
Zinc binding site 2 out
of 7 in 3s45
Go back to
Zinc Binding Sites List in 3s45
Zinc binding site 2 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn535
b:27.7
occ:0.50
|
OD2
|
A:ASP79
|
1.9
|
30.5
|
1.0
|
CG
|
A:ASP79
|
2.7
|
24.3
|
1.0
|
OD1
|
A:ASP79
|
2.8
|
32.6
|
1.0
|
CB
|
A:ASP79
|
4.2
|
21.5
|
1.0
|
|
Zinc binding site 3 out
of 7 in 3s45
Go back to
Zinc Binding Sites List in 3s45
Zinc binding site 3 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn536
b:26.0
occ:0.50
|
O
|
A:HOH1002
|
1.4
|
26.3
|
0.5
|
N3
|
A:IMD526
|
1.8
|
24.3
|
0.5
|
O
|
A:HOH1001
|
2.2
|
28.7
|
0.5
|
OE1
|
A:GLU65
|
2.2
|
41.1
|
1.0
|
C2
|
A:IMD526
|
2.6
|
25.1
|
0.5
|
C4
|
A:IMD526
|
2.9
|
23.9
|
0.5
|
CD
|
A:GLU65
|
3.2
|
37.4
|
1.0
|
OE2
|
A:GLU65
|
3.6
|
36.6
|
1.0
|
N1
|
A:IMD526
|
3.8
|
24.6
|
0.5
|
C5
|
A:IMD526
|
4.0
|
24.1
|
0.5
|
CG
|
A:GLU65
|
4.5
|
34.2
|
1.0
|
CB
|
A:GLU65
|
4.7
|
31.0
|
1.0
|
CD1
|
A:TYR14
|
4.8
|
31.8
|
1.0
|
CG
|
A:TYR14
|
4.9
|
30.9
|
1.0
|
|
Zinc binding site 4 out
of 7 in 3s45
Go back to
Zinc Binding Sites List in 3s45
Zinc binding site 4 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn531
b:13.8
occ:1.00
|
N3
|
B:IMD522
|
1.8
|
34.2
|
1.0
|
OE2
|
B:GLU21
|
1.9
|
15.3
|
1.0
|
N3
|
B:IMD521
|
2.1
|
15.7
|
1.0
|
C2
|
B:IMD522
|
2.2
|
36.1
|
1.0
|
CD
|
B:GLU21
|
2.7
|
14.2
|
1.0
|
OE1
|
B:GLU21
|
2.9
|
21.8
|
1.0
|
C2
|
B:IMD521
|
3.0
|
15.2
|
1.0
|
C4
|
B:IMD522
|
3.0
|
34.0
|
1.0
|
C4
|
B:IMD521
|
3.1
|
14.3
|
1.0
|
N1
|
B:IMD522
|
3.4
|
36.5
|
1.0
|
C5
|
B:IMD522
|
3.8
|
36.0
|
1.0
|
N1
|
B:IMD521
|
4.2
|
14.3
|
1.0
|
CG
|
B:GLU21
|
4.2
|
12.7
|
1.0
|
C5
|
B:IMD521
|
4.2
|
13.8
|
1.0
|
CG1
|
B:VAL10
|
4.8
|
21.2
|
1.0
|
|
Zinc binding site 5 out
of 7 in 3s45
Go back to
Zinc Binding Sites List in 3s45
Zinc binding site 5 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 5 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn532
b:13.2
occ:0.60
|
OD2
|
B:ASP30
|
1.9
|
21.5
|
1.0
|
CL
|
B:CL517
|
2.1
|
39.2
|
0.5
|
CL
|
B:CL512
|
2.3
|
15.2
|
0.6
|
N3
|
B:IMD523
|
2.3
|
12.5
|
0.6
|
C2
|
B:IMD523
|
2.6
|
11.4
|
0.6
|
CG
|
B:ASP30
|
2.9
|
16.2
|
1.0
|
OD1
|
B:ASP30
|
3.1
|
21.2
|
1.0
|
C4
|
B:IMD523
|
3.6
|
12.1
|
0.6
|
N1
|
B:IMD523
|
4.0
|
12.0
|
0.6
|
CB
|
B:ASP30
|
4.2
|
14.2
|
1.0
|
C5
|
B:IMD523
|
4.4
|
11.6
|
0.6
|
C1
|
B:478201
|
4.6
|
24.3
|
1.0
|
CB
|
B:ASP29
|
4.6
|
17.8
|
1.0
|
O6
|
B:478201
|
4.6
|
25.1
|
1.0
|
CG2
|
B:VAL47
|
4.6
|
14.0
|
1.0
|
CE
|
B:MET76
|
4.6
|
27.9
|
0.6
|
N
|
B:ASP30
|
5.0
|
12.9
|
1.0
|
|
Zinc binding site 6 out
of 7 in 3s45
Go back to
Zinc Binding Sites List in 3s45
Zinc binding site 6 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 6 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn534
b:21.9
occ:0.50
|
CL
|
B:CL518
|
2.0
|
33.2
|
0.5
|
CL
|
B:CL516
|
2.0
|
28.4
|
0.5
|
N3
|
B:IMD525
|
2.3
|
14.1
|
0.5
|
CL
|
B:CL515
|
2.4
|
24.0
|
0.5
|
C4
|
B:IMD525
|
3.1
|
13.5
|
0.5
|
C2
|
B:IMD525
|
3.4
|
13.4
|
0.5
|
CB
|
B:TRP6
|
4.0
|
20.2
|
1.0
|
CG
|
B:LYS7
|
4.3
|
19.0
|
1.0
|
C5
|
B:IMD525
|
4.3
|
13.3
|
0.5
|
N1
|
B:IMD525
|
4.5
|
13.2
|
0.5
|
CD
|
B:LYS7
|
4.6
|
21.7
|
1.0
|
N
|
B:LYS7
|
4.6
|
17.1
|
1.0
|
CE
|
B:LYS7
|
4.6
|
22.9
|
1.0
|
CG
|
B:TRP6
|
4.7
|
21.4
|
1.0
|
CD1
|
B:TRP6
|
4.7
|
21.3
|
1.0
|
CB
|
B:SER4
|
4.8
|
22.6
|
1.0
|
CA
|
B:TRP6
|
4.8
|
18.3
|
1.0
|
CB
|
B:LYS7
|
4.9
|
18.0
|
1.0
|
N
|
B:TRP6
|
4.9
|
15.5
|
1.0
|
C
|
B:TRP6
|
4.9
|
18.1
|
1.0
|
|
Zinc binding site 7 out
of 7 in 3s45
Go back to
Zinc Binding Sites List in 3s45
Zinc binding site 7 out
of 7 in the Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir
 Mono view
 Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 7 of Wild-Type Hiv-2 Protease with Antiviral Drug Amprenavir within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn537
b:26.0
occ:0.50
|
OE1
|
B:GLU65
|
1.7
|
25.4
|
1.0
|
O
|
B:HOH1013
|
1.7
|
25.2
|
1.0
|
CL
|
B:CL514
|
1.9
|
19.2
|
0.5
|
O
|
B:HOH1007
|
2.2
|
26.8
|
0.5
|
CD
|
B:GLU65
|
2.5
|
20.5
|
1.0
|
OE2
|
B:GLU65
|
2.7
|
28.7
|
1.0
|
O
|
B:HOH1024
|
3.5
|
15.0
|
1.0
|
CG
|
B:GLU65
|
4.0
|
17.0
|
1.0
|
NZ
|
B:LYS70
|
4.2
|
28.5
|
0.4
|
CA
|
B:GLY17
|
4.6
|
12.4
|
1.0
|
N
|
B:GLY17
|
4.7
|
11.9
|
1.0
|
CE
|
B:LYS70
|
4.8
|
26.1
|
0.4
|
CB
|
B:TYR14
|
4.9
|
9.6
|
1.0
|
|
Reference:
Y.Tie,
Y.F.Wang,
P.I.Boross,
T.Y.Chiu,
A.K.Ghosh,
J.Tozser,
J.M.Louis,
R.W.Harrison,
I.T.Weber.
Critical Differences in Hiv-1 and Hiv-2 Protease Specificity For Clinical Inhibitors. Protein Sci. V. 21 339 2012.
ISSN: ISSN 0961-8368
PubMed: 22238126
DOI: 10.1002/PRO.2019
Page generated: Sat Oct 26 15:33:01 2024
|